SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-004896
Filing Date
2019-04-10
Accepted
2019-04-10 17:35:33
Documents
1
Period of Report
2019-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1706
  Complete submission text file 0001179110-19-004896.txt   3165
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 14 CAMBRIDGE CENTER, BLDG 1 CAMBRIDGE MA 02142
Business Address
Csimma Cristina (Reporting) CIK: 0001501623 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31918 | Film No.: 19742400